| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Access barriers to anti-CD19+ CART therapy for NHL across a community transplant and cellular therapy network
|
Battiwalla, Minoo
|
|
|
9 |
2 |
p. 429-435
|
artikel
|
| 2 |
Amelioration of a von Willebrand disease type 2B phenotype in vivo upon treatment with allele-selective siRNAs
|
Linthorst, Noa A.
|
|
|
9 |
2 |
p. 310-320
|
artikel
|
| 3 |
A phase 2 multicenter trial of ruxolitinib to treat bronchiolitis obliterans syndrome after allogeneic HCT
|
DeFilipp, Zachariah
|
|
|
9 |
2 |
p. 244-253
|
artikel
|
| 4 |
Cerebral vascular shunting and oxygen metabolism in sickle cell disease
|
Song, Alexander K.
|
|
|
9 |
2 |
p. 386-397
|
artikel
|
| 5 |
CHIP away at the marrow-clot connection: inflammation, clonal hematopoiesis, and thromboembolic disease
|
Todorovski, Angela
|
|
|
9 |
2 |
p. 343-353
|
artikel
|
| 6 |
Deficit accumulation frailty index and treatment tolerability in AML: data from CALGB 11001 and 11002 (Alliance)
|
Lai, Catherine
|
|
|
9 |
2 |
p. 398-401
|
artikel
|
| 7 |
EASIX and m-EASIX predict CRS and ICANS in pediatric and AYA patients after CD19-CAR T-cell therapy
|
Zandaki, Dua’a
|
|
|
9 |
2 |
p. 270-279
|
artikel
|
| 8 |
Increased exercise tolerance in humanized G6PD-deficient mice
|
Cendali, Francesca I.
|
|
|
9 |
2 |
p. 321-334
|
artikel
|
| 9 |
Induction of factor VIII tolerance by hemophilia gene transfer to eradicate factor VIII inhibitors
|
Young, Guy
|
|
|
9 |
2 |
p. 265-269
|
artikel
|
| 10 |
Is GPIbα really a master regulator of platelet activation?
|
Watson, Brianna E.
|
|
|
9 |
2 |
p. 427-428
|
artikel
|
| 11 |
Maintenance of hematopoietic stem cells by tyrosine-unphosphorylated STAT5 and JAK inhibition
|
Williams, Matthew J.
|
|
|
9 |
2 |
p. 291-309
|
artikel
|
| 12 |
Medicaid coverage continuity is associated with lymphoma stage among children and adolescents/young adults
|
Zhang, Xinyue Elyse
|
|
|
9 |
2 |
p. 280-290
|
artikel
|
| 13 |
Midostaurin shapes macroclonal and microclonal evolution of FLT3-mutated acute myeloid leukemia
|
Joudinaud, Romane
|
|
|
9 |
2 |
p. 365-374
|
artikel
|
| 14 |
Optical genome mapping identified deletions, inversions, and insertions in hemophilia
|
Liu, Boyan
|
|
|
9 |
2 |
p. 360-364
|
artikel
|
| 15 |
Predicting CAR T-cell toxicity: insurance for CAR crashes
|
Shahid, Sanam
|
|
|
9 |
2 |
p. 335-336
|
artikel
|
| 16 |
Receiving CAR T-cells gets faster, but not for all in need
|
Ramos, Kristie N.
|
|
|
9 |
2 |
p. 436-438
|
artikel
|
| 17 |
Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab era
|
Fatola, Ayotola
|
|
|
9 |
2 |
p. 417-424
|
artikel
|
| 18 |
Single-cell multiomics reveal divergent effects of DNMT3A- and TET2-mutant clonal hematopoiesis in inflammatory response
|
Mohammed Ismail, Wazim
|
|
|
9 |
2 |
p. 402-416
|
artikel
|
| 19 |
T-cell immune cluster analysis using CyTOF identifies unique subgroups of patients with acute myeloid leukemia
|
Badar, Talha
|
|
|
9 |
2 |
p. 239-243
|
artikel
|
| 20 |
The E3 ubiquitin ligase MARCH5 promotes mitochondrial fusion and cell-cycle progression in acute myeloid leukemia
|
Larrue, Clément
|
|
|
9 |
2 |
p. 337-342
|
artikel
|
| 21 |
Therapies and outcomes following extramedullary relapse of pediatric and young adult ALL after CD19 CAR T-cell therapy
|
Friedes, Barbara D.
|
|
|
9 |
2 |
p. 354-359
|
artikel
|
| 22 |
Things (like AML salvage) go better with VEN(etoclax)
|
Winer, Eric S.
|
|
|
9 |
2 |
p. 425-426
|
artikel
|
| 23 |
Universal protection of allogeneic T-cell therapies from natural killer cells via CD300a agonism
|
Zhang, Shu-Qi
|
|
|
9 |
2 |
p. 254-264
|
artikel
|
| 24 |
Venetoclax-based salvage therapy as a bridge to transplant is feasible and effective in patients with relapsed/refractory AML
|
Unglaub, Julia M.
|
|
|
9 |
2 |
p. 375-385
|
artikel
|
Tijdschrift beschrijving